ADAMTS-10 (A Disintegrin And Metalloproteinase with Thrombospondin Motifs 10) is a member of the ADAMTS family of extracellular proteases, characterized by their zinc-dependent metalloproteinase and thrombospondin type 1 motif domains. ADAMTS-10 is primarily expressed in various tissues during embryonic development and plays crucial roles in extracellular matrix (ECM) remodeling, tissue morphogenesis, and cell migration. Functionally, ADAMTS-10 contributes to tissue homeostasis by regulating the turnover and organization of ECM components, including proteoglycans, collagen, and elastin. Its proteolytic activity enables the cleavage of ECM proteins, leading to structural modifications that influence cell behavior and tissue architecture. Additionally, ADAMTS-10 has been implicated in diverse physiological processes such as angiogenesis, wound healing, and skeletal development, highlighting its significance in both normal development and pathological conditions.
Activation of ADAMTS-10 is regulated by various mechanisms that control its enzymatic activity and substrate specificity. Post-translational modifications, such as glycosylation and proteolytic processing, can modulate ADAMTS-10 activity by affecting its stability, localization, and interaction with ECM substrates. Furthermore, interactions with other proteins and signaling molecules within the ECM microenvironment can regulate ADAMTS-10 function. For instance, binding of ECM proteins or cell surface receptors can induce conformational changes in ADAMTS-10, facilitating its activation and substrate recognition. Additionally, signaling pathways such as the MAPK/ERK pathway and the TGF-β signaling cascade have been implicated in the regulation of ADAMTS-10 expression and activity. Activation of these pathways can modulate ADAMTS-10 transcription, translation, or post-translational modifications, thereby influencing its proteolytic function and biological activity. Overall, the multifaceted regulation of ADAMTS-10 activation underscores its importance in ECM dynamics and tissue homeostasis, with implications for various physiological and pathological processes.
产品名称 | CAS # | 产品编号 | 数量 | 价格 | 应用 | 排名 |
---|---|---|---|---|---|---|
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
由于 TGF-β 信号通常会抑制 ADAMTS-10 的表达,SB431542 等 TGF-β 抑制剂可通过阻止 ADAMTS-10 的下调间接激活 ADAMTS-10。 | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
HDAC抑制剂(如Vorinostat)可能会通过调节表观遗传调控来激活ADAMTS-10,从而导致基因表达(包括ADAMTS-10的基因表达)增加。 | ||||||
L-Ascorbic acid, free acid | 50-81-7 | sc-202686 | 100 g | $45.00 | 5 | |
抗坏血酸等抑制胶原合成的化合物可通过减少胶原底物的可用性间接激活 ADAMTS-10,从而影响其活性。 | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $75.00 $265.00 | 55 | |
MMP 抑制剂(如 GM6001)可通过阻止 ECM 成分的降解间接激活 ADAMTS-10,从而保持 ADAMTS-10 作用所需的底物。 | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $150.00 $286.00 $479.00 $1299.00 $8299.00 $915.00 | 22 | |
Nrf2 激活剂(如红豆杉)可能会通过增强细胞抗氧化反应来激活 ADAMTS-10,从而影响氧化应激下的 ADAMTS-10 活性。 | ||||||
Dimethyloxaloylglycine (DMOG) | 89464-63-1 | sc-200755 sc-200755A sc-200755B sc-200755C | 10 mg 50 mg 100 mg 500 mg | $82.00 $295.00 $367.00 $764.00 | 25 | |
羟化酶抑制剂(如二甲基羟乙基甘氨酸)可能会通过调节翻译后修饰来激活 ADAMTS-10,并影响其稳定性或活性。 | ||||||
N-Acetyl-L-cysteine | 616-91-1 | sc-202232 sc-202232A sc-202232C sc-202232B | 5 g 25 g 1 kg 100 g | $33.00 $73.00 $265.00 $112.00 | 34 | |
ROS 清除剂(如 N-乙酰半胱氨酸)可通过减少氧化应激间接激活 ADAMTS-10,从而影响其在氧化性细胞外环境中的活性。 | ||||||
DAPT | 208255-80-5 | sc-201315 sc-201315A sc-201315B sc-201315C | 5 mg 25 mg 100 mg 1 g | $99.00 $335.00 $836.00 $2099.00 | 47 | |
像 DAPT 这样的 Notch 信号调节剂可能会通过改变细胞-细胞通信途径来影响 ADAMTS-10,从而影响其表达或活性。 |